Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery Yoshimitsu.

Slides:

Advertisements

Similar presentations

Superficial Femoral Artery Recanalization with Self-expanding Nitinol Stents: Long-term Follow-up Results M. Ferreira, L. Lanziotti, M. Monteiro, G.

Advertisements

A review of 100 consecutive reconstructions of the distal vertebral artery for embolic and hemodynamic disease Ramon Berguer, MD, PhD, Mark D. Morasch,

Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease Mahmoud B. Malas, MD, MHS, Ngozi Enwerem, MBBS, Umair.

A patient with multiple paradoxical emboli

Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents Yiu Che Chan, MBBS, BSc, MD, FRCS, Stephen W.

Incidence, predictors, and prognosis of in-stent occlusion after endovascular treatment with nitinol stents for femoropopliteal lesions Tomoharu Dohi,

Stenting of femoropopliteal lesions using interwoven nitinol stents

First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease Johannes Lammer, MD, Marc.

Contemporary outcomes after superficial femoral artery angioplasty and stenting: The influence of TASC classification and runoff score Daniel M. Ihnat,

A percutaneous arterial closure protocol can decrease complications after endovascular interventions in vascular surgery patients Philip P. Goodney,

Endovascular treatment of long lesions of the superficial femoral artery: Results from a multicenter registry of a spiral, covered polytetrafluoroethylene.

Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions Wei Ye, MD, Chang-Wei Liu,

Ali F. AbuRahma, MD, J. David Hayes, MD, Sarah K

Jayer Chung, MD, David A. Timaran, MD, J

Fifteen years of infrapopliteal arterial reconstructions with cryopreserved venous allografts for limb salvage Caren Randon, MD, Bart Jacobs, MD, Frederik.

Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventions Andrew M. Bakken, MD, Eugene Palchik, MD, Joseph P. Hart,

Adjunctive use of the superficial femoral vein for vascular reconstructions Soma Brahmanandam, MD, MPH, Daniel Clair, MD, James Bena, MS, Timur Sarac,

Endovascular management of iliac artery occlusions: extending treatment to TransAtlantic Inter-Society Consensus class C and D patients Christopher D.

The first operation on the profunda femoris artery

Outcomes of polytetrafluoroethylene-covered stent versus bare-metal stent in the primary treatment of severe iliac artery obstructive lesions Michele.

Michael S. Conte, MD Journal of Vascular Surgery

Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self- expanding stent graft versus prosthetic femoral-popliteal bypass in the.

Long-term results of direct and indirect endovascular revascularization based on the angiosome concept in patients with critical limb ischemia presenting.

Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent Bao-Ngoc Nguyen,

Impact of cilostazol after endovascular treatment for infrainguinal disease in patients with critical limb ischemia Yoshimitsu Soga, MD, Osamu Iida,

Miguel Montero-Baker, MD, Gregory J

Results of heparin-bonded ePTFE-covered stents for chronic occlusive superficial femoral artery disease Mare M.A. Lensvelt, MD, Wilbert M. Fritschy,

Clinical efficacy of endovascular therapy for patients with critical limb ischemia attributable to pure isolated infrapopliteal lesions Osamu Iida, MD,

Effect of perioperative complications after endovascular therapy in patients with peripheral artery disease due to femoropopliteal lesions Kei Sato,

Derek de Grijs, MD, Pedro Teixeira, MD, Steven Katz, MD

Christopher J. Smolock, MD, Javier E

Clinical efficacy of concomitant tibial interventions associated with superficial femoral artery interventions in critical limb ischemia Christopher.

Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery.

The number of patent tibial vessels does not influence primary patency after nitinol stenting of the femoral and popliteal arteries Jenny J. Lee, MD,

Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesions Osamu Iida, MD, Shinsuke Nanto, MD, Masaaki Uematsu,

Syed N. Haider, Eamon G. Kavanagh, MD, Martin Forlee, FCS (SA), Mary P

Open versus endoscopic great saphenous vein harvest for lower extremity revascularization of critical limb ischemia Vincent J. Santo, MD, Phong T. Dargon,

Infrainguinal cutting balloon angioplasty in de novo arterial lesions

Initial and 3-year results after subintimal versus intraluminal approach for long femoropopliteal occlusion treated with a self-expandable nitinol stent

Current efficacy of open and endovascular interventions for advanced superficial femoral artery occlusive disease Christopher J. Smolock, MD, Javier.

Pedal bypass surgery after crural endovascular intervention

Peter Neglén, MD, PhD, Kathryn C. Hollis, BA, Seshadri Raju, MD

The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé.

Stent placement for treatment of central and peripheral venous obstruction: A long-term multi-institutional experience Gustavo S.C. Oderich, MD, Gerald.

Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: A propensity-matched.

Primary stenting of the superficial femoral and popliteal artery

Toshifumi Kudo, MD, PhD, Fiona A. Chandra, Samuel S. Ahn, MD

Ilia Gur, MD, William Lee, MD, Gabriel Akopian, MD, Vincent L

Long-term results of combined common femoral endarterectomy and iliac stenting/stent grafting for occlusive disease Robert W. Chang, MD, Philip P. Goodney,

Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive.

Eric C. Scott, MD, Andre Biuckians, MD, MPH, Ryan E

Plaque excision with the Silverhawk catheter: Early results in patients with claudication or critical limb ischemia W. Brent Keeling, MD, Murray L. Shames,

Impact of runoff on superficial femoral artery endoluminal interventions for rest pain and tissue loss Mark G. Davies, MD, PhD, Wael E. Saad, MD, Eric.

Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease Hasan H.

Peripheral atherectomy in TransAtlantic InterSociety Consensus type C femoropopliteal lesions for limb salvage Andrea E. Yancey, MD, David J. Minion,

Karen J. Ho, MD, Christopher D. Owens, MD, MSc

Charles S. Joels, MD, John W. York, MD, Corey A. Kalbaugh, MS, David L

Donald T. Baril, MD, Luke K. Marone, MD, Justine Kim, Michael R

Gregory C. Schmieder, MD, Megan Carroll, BA, BS, Jean M. Panneton, MD

Infrapopliteal angioplasty for critical limb ischemia: Relation of TransAtlantic InterSociety Consensus class to outcome in 176 limbs Kristina A. Giles,

James E. Edwards, MD, Lloyd M. Taylor, MD, John M. Porter, MD

Efficacious use of nitinol stents in the femoral and popliteal arteries Todd R Vogel, MD, Larry E Shindelman, MD, Gary B Nackman, MD, Alan M Graham, MD

Impact of Dual Antiplatelet Therapy on Superficial Femoral Artery Stent Patency in the Vascular Study Group of New England Ryan M. Svoboda, Karina A.

The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: A 10-year experience Toshifumi Kudo, MD, PhD,

The treatment of disabling intermittent claudication in patients with superficial femoral artery occlusive disease—Decision analysis Brian Nolan, MD,

Endovascular interventions for TASC II D femoropopliteal lesions

Stroke and death after carotid endarterectomy and carotid artery stenting with and without high risk criteria Kristina A. Giles, MD, Allen D. Hamdan,

Iliac artery stenting versus surgical reconstruction for TASC (transatlantic inter-society consensus) type B and type C iliac lesions Carlos H Timaran,

Scott M. Surowiec, MD, Mark G. Davies, MD, PhD, Shirley W

Isolated femoral endarterectomy: Impact of SFA TASC classification on recurrence of symptoms and need for additional intervention Georges Al-Khoury,

Presentation transcript:

Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery Yoshimitsu Soga, MD, Osamu Iida, MD, Keisuke Hirano, MD, Kenji Suzuki, MD, Atsushi Tosaka, MD, Hiroyoshi Yokoi, MD, Masakiyo Nobuyoshi, MD Journal of Vascular Surgery Volume 54, Issue 4, Pages 1058-1066 (October 2011) DOI: 10.1016/j.jvs.2011.03.286 Copyright © 2011 Society for Vascular Surgery Terms and Conditions

Fig 1 Overall primary and secondary patency in 1001 limbs after stent placement with self-expandable nitinol stent in superficial femoral artery. Journal of Vascular Surgery 2011 54, 1058-1066DOI: (10.1016/j.jvs.2011.03.286) Copyright © 2011 Society for Vascular Surgery Terms and Conditions

Fig 2 Primary patency among low-, moderate-, and high-risk patients. Journal of Vascular Surgery 2011 54, 1058-1066DOI: (10.1016/j.jvs.2011.03.286) Copyright © 2011 Society for Vascular Surgery Terms and Conditions

Fig 3 Secondary patency among low-, moderate-, and high-risk patients. Journal of Vascular Surgery 2011 54, 1058-1066DOI: (10.1016/j.jvs.2011.03.286) Copyright © 2011 Society for Vascular Surgery Terms and Conditions

Fig 4 Overall survival in low-, moderate-, and high-risk patients. Journal of Vascular Surgery 2011 54, 1058-1066DOI: (10.1016/j.jvs.2011.03.286) Copyright © 2011 Society for Vascular Surgery Terms and Conditions

Fig 5 Primary patency among TransAtlantic InterSociety Consensus (TASC) II classification. Journal of Vascular Surgery 2011 54, 1058-1066DOI: (10.1016/j.jvs.2011.03.286) Copyright © 2011 Society for Vascular Surgery Terms and Conditions

Fig 6 Primary patency in low-, moderate-, and high-risk patients with TASC II C/D lesion. TASC, TransAtlantic InterSociety Consensus. Journal of Vascular Surgery 2011 54, 1058-1066DOI: (10.1016/j.jvs.2011.03.286) Copyright © 2011 Society for Vascular Surgery Terms and Conditions